Goldman Sachs analyst expects positive updates from Vertex's first Investor Day as a public company on March 19, reiterates ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Ange Postecoglou is on the brink after Liverpool smashed Tottenham to knock them out of the Carabao Cup and Aston Villa eased them out of the FA Cup three days later. Which poor sod will be left ...

Italy is often thought of as a political laboratory, anticipating events in other countries: fascism in the 1920s; the showman-businessman turned politician in the 1990s; populism in the 2010s. Great ...

After hours: March 21 at 7:13:50 PM EDT Loading Chart for VRTX ...

Congress leader Malliakarjun Kharge intends to pursue legal action against BJP's JP Nadda and Kiren Rijiju for allegedly making false claims that Congress is providing reservations based on ...